The World Health Organization (WHO) has announced the establishment of a Guideline Development Group (GDG) to develop the first evidence-based recommendations on multiplex testing for HIV, viral hepatitis, and sexually transmitted infections (STIs)..
.jpeg "Reckitt Launches Maternal & Child Health Tech Accelerator")
Reckitt has also joined with PATH and the Centre of Health Research and Innovation (CHRI) to start the Dettol Banega Swasth India - Maternal and Child Health Tech Accelerator. This platform creates an opportunity to invite the most innovative ideas o
.jpg "Navin Fluorine Launches cGMP-4 Plant at Dewas")
Navin Fluorine International Limited (NFIL) achieved a milestone with the launch of Phase-1 of its new cGMP-4 plant at the Navin Molecular location within its Dewas unit. The launch, in front of its distinguished European pa...
Hyderabad-based Dr Reddy's Laboratories said on Tuesday that it has finalized a definitive transaction the Stugeron brand from Johnson & Johnson across the EMEA countries, describing India and Vietnam as important growth markets for Stugeron...
Botanic Healthcare, an international leader in natural ingredients, nutraceutical development, has launched its cutting-edge Liposomal Manufacturing Facility in Hyderabad, India, representing a major advancement in enhanced delivery technologies...
Schneider Electric, the global specialist in digital energy management and automation, has partnered with Apollo Hospitals, Asia's broadest integrated healthcare provider, to boost energy reliability at Apollo Proton Cancer Centre (APCC) in Chennai..
Artificial intelligence (AI) is being seen by the Indian healthcare industry as a strategic necessity that will enable next-generation treatments and increase systemic efficiency throughout the industry
Tata Elxsi, a global leader in design and technology services, announced the inauguration of the ‘Bayer Development Centre in Radiology’ at Tata Elxsi, Pune, India
Emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA), has been given Fast Track designation by the U.S. Food and Drug Administration (FDA), according to a statement released today by Teva Pharmaceuticals
The U.S. Food and Drug Administration (FDA) has approved Inlexzo, the first drug delivery system from Johnson & Johnson, for patients with high-risk non-muscle invasive bladder cancer who have failed standard Bacillus Calmette-Guerin (BCG) therapy...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")